Efficacy of Bezlotoxumab in Preventing Recurrent Clostridioides Difficile Infection: A Narrative Review. AMMS [Internet]. 2025 Sep. 20 [cited 2025 Dec. 24];:1096-102. Available from: http://ammspub.com/index.php/amms/article/view/329